Summary & Overview
HCPCS G0308: Insertion of 180-Day Implantable Interstitial Glucose Sensor
HCPCS Level II code G0308 covers the creation of a subcutaneous pocket and insertion of a 180-day implantable interstitial glucose sensor, including system activation and patient training. This code captures a growing category of long-term continuous glucose monitoring (CGM) interventions that enable extended glucose surveillance for patients with diabetes or complex glycemic management needs. Nationally, implantable long-duration CGM devices are increasingly relevant for chronic disease management, reducing the need for frequent fingersticks and episodic monitoring.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find benchmarks and programmatic context for coverage and coding considerations, an overview of clinical workflow implications (implantation, activation, and patient education), and discussion of where this code fits within outpatient procedural billing. The publication summarizes common payer coverage patterns, reimbursement considerations, and operational factors for ambulatory and hospital outpatient settings. Data not available in the input is noted where applicable, and clinical context is provided to clarify the procedure's role in long-term glucose management. The material is intended to inform billing, coding, and administrative stakeholders nationwide about the use and classification of G0308 in current practice.
Billing Code Overview
HCPCS Level II code G0308 describes the creation of a subcutaneous pocket with insertion of a 180-day implantable interstitial glucose sensor, and includes system activation and patient training. This procedure involves placing a long-term continuous glucose monitoring (CGM) sensor in a subcutaneous pocket designed for a 180-day implantable device, activating the monitoring system, and providing initial patient education on device use and maintenance.
Service type: Device implantation with system activation and patient training
Typical site of service: Ambulatory surgical center or hospital outpatient setting, including same-day procedure suites where minor implantable device insertion is performed.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with insulin-requiring diabetes mellitus who experiences challenges with glycemic variability or hypoglycemia unawareness and is being considered for long-term continuous interstitial glucose monitoring. The patient presents to an ambulatory surgical center or office-based procedure suite for insertion of a 180‑day implantable interstitial glucose sensor. Pre-procedure evaluation includes diabetes history, medication reconciliation (especially anticoagulants), assessment for skin infection at the insertion site, and informed consent that addresses risks such as infection, bleeding, sensor migration, or device malfunction.
On the day of the procedure the patient is positioned supine, the planned subcutaneous pocket site (commonly upper arm) is marked and prepped in a sterile fashion. Local anesthesia is administered. A small incision and subcutaneous pocket are created and the implantable sensor is placed. The device system is activated per manufacturer protocol, function is verified, and initial calibration or baseline readings are obtained if required. The clinician provides immediate patient training on device use, troubleshooting, wound care, activity restrictions, and scheduling of follow-up for sensor checks and eventual removal at 180 days. Typical sites of service are ambulatory surgical center (ASC), office-based procedure suite, or hospital outpatient department depending on patient comorbidities and payer requirements.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 |